The DOI matches its Crossref record.
Fetal valproate syndrome.
Open accessAbstract
flat nasal bridge, broad nasal root, antiverted nares, shallow philtrum, long upper lip and thin vermillion borders, thick lower lip, small [8] downturned mouth. Our case had developmental delay, growth retardation, consistent facial dysmorphism, microcephaly, loose skin, hypspadias, hypotonia, congenital heart defect (ASD and PDA) and Arnold chiari I malformation. We found Arnold chiari type I malformation which is not reported in literature as per my knowledge. Association of developmental delay and learning disabilities with FVS is frequently [7,8] described. Joint laxity and hypotonia is observed with all [9] anticonvulsants including VPA. There is increase in incidence of NTD at around 10 times and congenital heart disease at around 4 times in fetuses exposed to VPA than normal. NTD specifically related to valproate therapy, rather than [6] to other anticonvulsants. NTD can be detected antenatally by maternal alpha fetoprotein level and targeted ultrasonography. To decrease the risk of NTD with VPA, high dose folic acid (4 mg/day) is recommended during pregnancy, starting at least 6 weeks [10] preconception and continuing through the first trimester. In our case, no specific test was done antenatally and mother didn't receive folic acid. Valproic acid (VPA) is a teratogenic drug widely used for treatment of seizures and mood disorder. Fetal valproate syndrome (FVS) results from in utero exposure of fetus to VPA. It is characterised by presence of consistent facial dysmorphism, group of minor and major malformations and developmental delay. We report a case of 1 year old boy presented with features of FVS with Arnold chiari I malformation and reviewed literature. ABSTRACT
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The valproic acid-induced rodent model of autism
Nicolini, C., & Fahnestock, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.017 · Cited by 592
The longer term outcome of children born to mothers with epilepsy
Adab, N. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029132 · Cited by 580
A clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
Molecular and Therapeutic Potential and Toxicity of Valproic Acid
Chateauvieux, S., Morceau, F., Dicato, M., & Diederich, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/479364 · Cited by 512
Fetal valproate syndrome and autism: additional evidence of an association
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., & Hersh, J. H. (2001) · Developmental Medicine and Child Neurology · doi:10.1017/s001216220100038x · Cited by 422
Metadata
- Authors
- Clayton-Smith, J., & Donnai, D.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 1995-09
- Volume
- 32
- Issue
- 9
- Pages
- 724-727
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2167746292
- Cited by
- 164
- References
- 0
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fetal valproate syndrome. https://app.cochat.ai/papers/10.1136/jmg.32.9.724
- The paper
- Clayton-Smith, J., & Donnai, D. (1995). Fetal valproate syndrome. Journal of Medical Genetics. https://doi.org/10.1136/jmg.32.9.724
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.